Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (11-20 of 1,153) with videos related to

Pageof 116
Sort By:
The New England Journal of Medicine|February 8, 1996
Drugs in cardiac transplantationC M Ballantyne
The American Journal of Cardiology|October 10, 1998
Clinical trial endpoints: angiograms, events, and plaque instabilityC M Ballantyne
The American Journal of Cardiology|September 2, 2003
Current and future aims of lipid-lowering therapy: changing paradigms and lessons from the Heart Protection Study on standards of efficacy and safetyChristie M Ballantyne
Clinical Cornerstone|October 20, 2007
Treatment of dyslipidemia to reduce cardiovascular risk in patients with multiple risk factorsChristie M Ballantyne
International Journal of Clinical Practice. Supplement|September 26, 2002
Familial hypercholesterolaemia: optimum treatment strategiesC M Ballantyne
The American Journal of Managed Care|June 1, 2001
Surrogate endpoints and newer risk markers in atherosclerosis managementC M Ballantyne
Circulation|September 26, 2001
September 11, 2001C M Ballantyne
Journal of the American College of Cardiology|July 6, 2019
Lipoprotein(a) and Risk for Stroke and Myocardial Infarction: Why Aren't We Screening?Christie M Ballantyne
Current Atherosclerosis Reports|December 21, 2000
Reducing atherothrombotic events in high-risk patients: recent data on therapy with statins and fatty acidsC M Ballantyne
Current Atherosclerosis Reports|December 21, 2000
Development and assessment of antiatherosclerotic therapies beyond low-density lipoprotein cholesterol and blood pressureC M Ballantyne
Pageof 116

Showing results (11-20 of 1,153) with videos related to

Sort By:
Pageof 116
The New England Journal of Medicine|February 8, 1996
Drugs in cardiac transplantationC M Ballantyne
The American Journal of Cardiology|October 10, 1998
Clinical trial endpoints: angiograms, events, and plaque instabilityC M Ballantyne
The American Journal of Cardiology|September 2, 2003
Current and future aims of lipid-lowering therapy: changing paradigms and lessons from the Heart Protection Study on standards of efficacy and safetyChristie M Ballantyne
Clinical Cornerstone|October 20, 2007
Treatment of dyslipidemia to reduce cardiovascular risk in patients with multiple risk factorsChristie M Ballantyne
International Journal of Clinical Practice. Supplement|September 26, 2002
Familial hypercholesterolaemia: optimum treatment strategiesC M Ballantyne
The American Journal of Managed Care|June 1, 2001
Surrogate endpoints and newer risk markers in atherosclerosis managementC M Ballantyne
Circulation|September 26, 2001
September 11, 2001C M Ballantyne
Journal of the American College of Cardiology|July 6, 2019
Lipoprotein(a) and Risk for Stroke and Myocardial Infarction: Why Aren't We Screening?Christie M Ballantyne
Current Atherosclerosis Reports|December 21, 2000
Reducing atherothrombotic events in high-risk patients: recent data on therapy with statins and fatty acidsC M Ballantyne
Current Atherosclerosis Reports|December 21, 2000
Development and assessment of antiatherosclerotic therapies beyond low-density lipoprotein cholesterol and blood pressureC M Ballantyne
Pageof 116